Sequential Treatment of Metastatic Adenocarcinoma of the Pancreatic Duct with Liver Metastasis Following the NAPOLI-1 Study Protocol with nal-Irinotecan plus 5-FU in the Second Line

Pancreatic ductal adenocarcinoma (PDAC) is typically diagnosed at an advanced or metastatic stage, when curative surgery is not recommended. Therefore, the prognosis is poor for this dismal disease, with only 1–2% of the patients reaching the 5-year survival follow-up. Current advances in systemic t...

Descripción completa

Detalles Bibliográficos
Autores principales: Akhoundova Sanoyan, Dilara, Reiner, Cäcilia S., Papageorgiou, Panagiota, Siebenhüner, Alexander R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036570/
https://www.ncbi.nlm.nih.gov/pubmed/32110224
http://dx.doi.org/10.1159/000504471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036570/
https://www.ncbi.nlm.nih.gov/pubmed/32110224
http://dx.doi.org/10.1159/000504471

Ejemplares similares